RT Journal Article
SR Electronic
A1 Vinall, Phil
T1 What's New in Antiretroviral Therapy
JF MD Conference Express
YR 2012
FD SAGE Publications
VO 12
IS 14
SP 19
OP 20
DO 10.1177/155989771214008
UL http://mdc.sagepub.com/content/12/14/19.abstract
AB Current guidelines recommend non-nucleoside reverse transcriptase inhibitor (NNRTI)-based, boosted protease inhibitor (PI)-based, and integrase strand transfer inhibitor (INSTI)-based regimens for the treatment of HIV [http://aidsinfo.nih.gov/Guidelines/HTML/1/adult-and-adolescent-treatment-guidelines/0; Thompson MA et al. JAMA 2012]. This article discusss recent data from clinical trials comparing initial antiretroviral regimens and factors to be considered when starting antiretroviral therapy.